SONNET BIOTHERAPEUTICS

sonnet-biotherapeutics-logo

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action. The company 's proprietary FHAB™ (Fully Human Albumin Binding) technology enables the development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms. The FHAB™ platform utilizes a fully human single-chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. Son... net’s FHAB construct attaches to albumin in the bloodstream, which significantly enhances the pharmacokinetics of the active drug substance. It also naturally accumulates at inflammation sites, including tumors, thereby potentiating delivery to target tissues. The Sonnet platform is differentiated in that FHAB utilizes a fully human sequence, with a human glycosylation profile that can be manufactured using a standard CHO process.
#People #Financial #Website #More

SONNET BIOTHERAPEUTICS

Social Links:

linkedin

Linkedin

facebook

Facebook

x

X

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2011-01-01

Address:
Princeton, New Jersey, United States

Country:
United States

Website Url:
http://www.sonnetbio.com

Total Employee:
1+

Status:
Active

Contact:
609-375-2227

Email Addresses:
[email protected]

Total Funding:
30.75 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving


Current Employees Featured

not_available_image

Susan Dexter
Susan Dexter Chief Technical Officer @ Sonnet BioTherapeutics
Chief Technical Officer

not_available_image

Dorr Andrew
Dorr Andrew Chief Medical Officer @ Sonnet BioTherapeutics
Chief Medical Officer

not_available_image

John K. Cini
John K. Cini Co-Founder and Chief Scientific Officer @ Sonnet BioTherapeutics
Co-Founder and Chief Scientific Officer

pankaj-mohan_image

Pankaj Mohan
Pankaj Mohan Co-Founder, CEO & Chairman @ Sonnet BioTherapeutics
Co-Founder, CEO & Chairman

not_available_image

Jay Cross
Jay Cross CFO @ Sonnet BioTherapeutics
CFO

Founder


not_available_image

John K. Cini

pankaj-mohan_image

Pankaj Mohan

Stock Details


Company's stock symbol is NASDAQ:SONN

Acquisitions List

Date Company Article Price
2020-04-01 Chanticleer Holdings Chanticleer Holdings acquired by Sonnet BioTherapeutics N/A

Official Site Inspections

http://www.sonnetbio.com Semrush global rank: 4.7 M Semrush visits lastest month: 2.05 K

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Sonnet BioTherapeutics" on Search Engine